276 related articles for article (PubMed ID: 25792456)
1. [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Tago T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1052-61. PubMed ID: 25792456
[TBL] [Abstract][Full Text] [Related]
2. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
3. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Comparison of Tau Radioligands
Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
Harada R; Okamura N; Furumoto S; Tago T; Maruyama M; Higuchi M; Yoshikawa T; Arai H; Iwata R; Kudo Y; Yanai K
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):125-32. PubMed ID: 23100049
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
Ishiki A; Okamura N; Furukawa K; Furumoto S; Harada R; Tomita N; Hiraoka K; Watanuki S; Ishikawa Y; Tago T; Funaki Y; Iwata R; Tashiro M; Yanai K; Kudo Y; Arai H
PLoS One; 2015; 10(10):e0140311. PubMed ID: 26461913
[TBL] [Abstract][Full Text] [Related]
7. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
Villemagne VL; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Hodges J; Harada R; Yates P; Piguet O; Pejoska S; Doré V; Yanai K; Masters CL; Kudo Y; Rowe CC; Okamura N
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):816-26. PubMed ID: 24514874
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Vallabhajosula S
Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
[TBL] [Abstract][Full Text] [Related]
11. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
[TBL] [Abstract][Full Text] [Related]
13. Tau imaging with [
Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
15. [
Kobayashi R; Hayashi H; Kawakatsu S; Ishiki A; Okamura N; Arai H; Otani K
BMC Neurol; 2018 Aug; 18(1):109. PubMed ID: 30089453
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
17. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
[TBL] [Abstract][Full Text] [Related]
18. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
19. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
[TBL] [Abstract][Full Text] [Related]
20. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
Lemoine L; Saint-Aubert L; Marutle A; Antoni G; Eriksson JP; Ghetti B; Okamura N; Nennesmo I; Gillberg PG; Nordberg A
Acta Neuropathol Commun; 2015 Jul; 3():40. PubMed ID: 26134112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]